{"id":"erythromycin-ointment","safety":{"commonSideEffects":[{"rate":null,"effect":"Local irritation or burning"},{"rate":null,"effect":"Allergic contact dermatitis"},{"rate":null,"effect":"Temporary blurred vision"}]},"_chembl":{"chemblId":"CHEMBL2108523","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Erythromycin works by penetrating bacterial cells and binding to the 50S ribosomal subunit, thereby inhibiting peptide bond formation and halting protein synthesis. This bacteriostatic action prevents bacterial replication and allows the immune system to clear the infection. When applied topically as an ointment, it achieves high local concentrations at the site of infection while minimizing systemic exposure.","oneSentence":"Erythromycin ointment is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, reducing bacterial growth and infection.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:11:27.322Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial conjunctivitis"},{"name":"Neonatal ophthalmia prophylaxis"},{"name":"Bacterial eye infections"}]},"trialDetails":[{"nctId":"NCT04185402","phase":"PHASE4","title":"Azithromycin Reduction to Reach Elimination of Trachoma","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2021-05-29","conditions":"Trachoma","enrollment":3931},{"nctId":"NCT06289647","phase":"PHASE4","title":"Azithromycin Reduction to Reach Elimination of Trachoma B","status":"WITHDRAWN","sponsor":"University of California, San Francisco","startDate":"2024-10","conditions":"Trachoma","enrollment":""},{"nctId":"NCT06879119","phase":"NA","title":"Clinical Evaluation of Localized Scalp Thread Embedding for Male Androgenetic Alopecia","status":"COMPLETED","sponsor":"Beijing University of Chinese Medicine, Shenzhen Hospital","startDate":"2021-05-27","conditions":"Androgenetic Alopecia","enrollment":9},{"nctId":"NCT02875158","phase":"NA","title":"Cyclophotocoagulation in Glaucoma","status":"COMPLETED","sponsor":"CHU de Quebec-Universite Laval","startDate":"2016-08","conditions":"Glaucoma","enrollment":44},{"nctId":"NCT03173053","phase":"NA","title":"S. Aureus Decolonization in HPN Patients.","status":"TERMINATED","sponsor":"Radboud University Medical Center","startDate":"2018-02-08","conditions":"Staphylococcus Aureus, Motility Disorder","enrollment":63},{"nctId":"NCT04617626","phase":"NA","title":"Resiliency Through Azithromycin for Children (REACH), Côte d'Ivoire","status":"COMPLETED","sponsor":"FHI 360","startDate":"2020-11-20","conditions":"Child Mortality, Azithromycin","enrollment":1735},{"nctId":"NCT01560962","phase":"NA","title":"Efficacy of Over the Counter (OTC) Povidone-Ioldine 5% for Treatment of Acute or Chronic Blepharitis","status":"TERMINATED","sponsor":"Southern California Institute for Research and Education","startDate":"2012-01","conditions":"Blepharitis","enrollment":100},{"nctId":"NCT03199911","phase":"PHASE4","title":"Topical Antibiotic Prophylaxis for Eyelids","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2017-10-02","conditions":"Antibiotic Side Effect, Eyelid; Wound, Eyelid Diseases","enrollment":401},{"nctId":"NCT01229553","phase":"NA","title":"Effect of Topical and Systemic Decolonization of Staphylococcus Aureus (SA) in Pediatric Cystic Fibrosis (CF) Patients","status":"WITHDRAWN","sponsor":"State University of New York - Upstate Medical University","startDate":"2011-01","conditions":"Cystic Fibrosis","enrollment":""},{"nctId":"NCT01478256","phase":"PHASE4","title":"Comparative Study in the Efficacy of Topical Besifloxocin With Erythromycin for the Management of Acute Blepharitis","status":"COMPLETED","sponsor":"John, George, M.D.","startDate":"2011-08","conditions":"Blepharitis","enrollment":30},{"nctId":"NCT01961193","phase":"NA","title":"A Comparison Between Bandage Contact Lens, Punctal Plugs and Standard Measures in Preventing Corneal Injuries","status":"UNKNOWN","sponsor":"Rabin Medical Center","startDate":"2015-05","conditions":"Contact Lens and Punctal Plug in Preventing Corneal Injuries","enrollment":105},{"nctId":"NCT00000120","phase":"PHASE3","title":"Clinical Trial of Eye Prophylaxis in the Newborn","status":"COMPLETED","sponsor":"National Eye Institute (NEI)","startDate":"1985-01","conditions":"Chlamydia Infections, Ophthalmia Neonatorum","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":69,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Erythromycin Ointment","genericName":"Erythromycin Ointment","companyName":"National Eye Institute (NEI)","companyId":"national-eye-institute-nei","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Erythromycin ointment is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, reducing bacterial growth and infection. Used for Bacterial conjunctivitis, Neonatal ophthalmia prophylaxis, Bacterial eye infections.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}